Clinical trial registry record

Analysis of Frailty Syndrome Within the Framework of the Innovation Fund Project PRÄP-GO (ANA-PRÄP-GO)

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated August 26, 2025.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT04880824
Last registry update
August 26, 2025
Status
Completed
Phase
Phase not reported
Sponsor
Charite University, Berlin, Germany
Enrollment
693
Countries
Germany
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
OBSERVATIONAL
Evidence population
Human clinical study registration
Participants
693
Population
ALL · 70 Years
Duration
2021-05-19 to 2025-03-21
Intervention
Prehabilitation- new form of care
Comparator
Not reported
Outcomes measured
Frailty — Up to 1 year; Neuro-cognitive disorder (NCD) — Up to 1 year; Incidence of delirium — During the hospital stay, an expected average of 1 week; Severity of delirium — During the hospital stay, an expected average of 1 week; Nursing Delirium Screening Scale (Nu-DESC) — During the hospital stay, an expected average of 1 week; Confusion Assessment Method (CAM) — During the hospital stay, an expected average of 1 week; Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) — During the hospital stay, an expected average of 1…; Confusion Assessment Method Severity-Score (CAM-S Long Form) in English — During the hospital stay, an expected average…; Intensive Care Delirium Screening Checklist (ICDSC) — During the hospital stay, an expected average of 1 week; Delirium Rating Scale Revised 98 in English (DRS-R-98) — During the hospital stay, an expected average of 1 week; Delirium Severity Scale (CAM-ICU-7) in English — During the hospital stay, an expected average of 1 week; Number of Participants with Delirium as Determined by Chart Review — During the hospital stay, an expected average of 1…; Delirium days — During the hospital stay, an expected average of 1 week; COVID-19 — Up to 1 year; Cardiovascular function 1 — Up to 1 year; Cardiovascular function 2 — Up to 1 year; Ethical aspects — Up to 1 year; Patient satisfaction — Up to 1 year; Patient-related outcome measures (PROMS) — Up to 1 year; Patient-related experience measures (PREMS) — Up to 1 year
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Frailty · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Source terminology contains a controlled topic term. Title supplies ageing or longevity context.

Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.